San Mateo, CA-based Route 92 Medical will accelerate global commercialization of its neurovascular intervention portfolio and pursue regulatory authorizations in new geographies with a $50m extension to its Series F financing round announced in November 2023.
The extension – compliments of returning investors US Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group, as...